Compounds > 2-chloro-n(6)cyclopentyladenosine
Page last updated: 2024-09-03

2-chloro-n(6)cyclopentyladenosine and quinazolines

2-chloro-n(6)cyclopentyladenosine has been researched along with quinazolines in 4 studies

Compound Research Comparison

Studies
(2-chloro-n(6)cyclopentyladenosine)		Trials
(2-chloro-n(6)cyclopentyladenosine)		Recent Studies (post-2010)
(2-chloro-n(6)cyclopentyladenosine)		Studies
(quinazolines)		Trials
(quinazolines)		Recent Studies (post-2010) (quinazolines)
25204319,2352,4178,835

Protein Interaction Comparison

ProteinTaxonomy2-chloro-n(6)cyclopentyladenosine (IC50)quinazolines (IC50)
Epidermal growth factor receptorHomo sapiens (human)0.027

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Amoroso, S; Annunziato, L; Di Renzo, G; Iannotti, E; Saggese, ML1
Borchard, U; Felsch, A; Stöcker, K1
Conti, A; Dionisotti, S; Gatta, F; Ongini, E; Sandoli, D; Zocchi, C1
Cutler, BS; Dobson, JG; Fenton, RA; Li, Jm; Peyton, BD; Powell, CC; Wheeler, HB1

Other Studies

4 other study(ies) available for 2-chloro-n(6)cyclopentyladenosine and quinazolines

ArticleYear
The A1 agonist CCPA reduced bisoxonol-monitored membrane potential depolarization elicited by high K+ in cerebrocortical nerve endings.
    Biochimica et biophysica acta, 1995, Oct-04, Volume: 1239, Issue:1

    Topics: Adenosine; Animals; Cerebral Cortex; Fluorescent Dyes; Male; Membrane Potentials; Nerve Endings; Phenethylamines; Potassium; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Quinazolines; Rats; Rats, Wistar; Synaptosomes; Thiobarbiturates; Triazoles; Veratridine; Xanthines

1995
Adenosine A1 and A2 receptor agonists alter cardiac functions and prostacyclin release in the isolated guinea-pig heart.
    European journal of pharmacology, 1994, Oct-03, Volume: 263, Issue:3

    Topics: 6-Ketoprostaglandin F1 alpha; Adenosine; Animals; Antihypertensive Agents; Cardiac Pacing, Artificial; Cells, Cultured; Coronary Circulation; Dose-Response Relationship, Drug; Endothelium, Vascular; Epoprostenol; Guinea Pigs; Heart; Heart Rate; Male; Myocardium; Phenethylamines; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Quinazolines; Triazoles; Vasodilation; Ventricular Function, Left; Xanthines

1994
Effects of the new A2 adenosine receptor antagonist 8FB-PTP, an 8 substituted pyrazolo-triazolo-pyrimidine, on in vitro functional models.
    British journal of pharmacology, 1994, Volume: 112, Issue:2

    Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Cattle; In Vitro Techniques; Male; Muscle, Smooth, Vascular; Phosphoric Diester Hydrolases; Platelet Aggregation; Purinergic P1 Receptor Antagonists; Pyrimidines; Quinazolines; Rabbits; Rats; Rats, Sprague-Dawley; Triazoles; Vasodilator Agents; Xanthines

1994
Adenosine A2a receptors increase arterial endothelial cell nitric oxide.
    The Journal of surgical research, 1998, Volume: 80, Issue:2

    Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Carotid Arteries; Cells, Cultured; Endothelium, Vascular; Humans; Iliac Artery; Nitric Oxide; Phenethylamines; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Quinazolines; Receptor, Adenosine A2A; Receptors, Purinergic P1; Swine; Triazines; Triazoles; Xanthines

1998